csirt@kutim:~/threat-intel/cve/CVE-2026-53185

Katalog CVE

CVSS 7.8 · High EPSS 0,11%

Kerentanan Use After Free pada linux kernel. Skor CVSS 3.1 7.8 (High) menurut CNA.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: zram: fix use-after-free in zram_bvec_write_partial() zram_read_page() picks the sync or async backing device read path based on whether the parent bio is NULL. zram_bvec_write_partial() passes its parent bio down, so for ZRAM_WB slots the read is dispatched asynchronously and zram_read_page() returns 0 while the bio is still in flight. The caller then runs memcpy_from_bvec(), zram_write_page() and __free_page() on the buffer, leaving the async read to write into a freed page. zram_bvec_read_partial() was switched to NULL in commit 4e3c87b9421d ("zram: fix synchronous reads") for the same reason; the write_partial counterpart was missed.

Advisory KUTIM-CSIRT

Rincian

Terbit di NVD
25 Juni 2026
Terakhir diubah
9 September 2026
Status NVD
Modified
CVSS 3.1
7.8 (High), sumber CNA
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-416: Use After Free
CWE-364: Signal Handler Race Condition
EPSS (30 hari)
0,11% peluang dieksploitasi; lebih tinggi dari 1,0% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Versi 4.14 hingga sebelum 6.6.143
linux linux kernel Versi 6.7 hingga sebelum 6.12.94
linux linux kernel Versi 6.13 hingga sebelum 6.18.36
linux linux kernel Versi 6.19 hingga sebelum 7.0.13
linux linux kernel Versi 7.1 rc1
linux linux kernel Versi 7.1 rc2
linux linux kernel Versi 7.1 rc3
linux linux kernel Versi 7.1 rc4
linux linux kernel Versi 7.1 rc5
linux linux kernel Versi 7.1 rc6
linux linux kernel Versi 7.1 rc7

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.